Gadoxetic acid-enhanced MRI-derived functional liver imaging score (FLIS) and spleen diameter predict outcomes in ACLD.

导出 LinkOut

翻译打印收藏纠错

第一作者： Nina,Bastati

第一单位： Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria.

作者： Nina,Bastati ^[1] ; Lucian,Beer ^[1] ; Ahmed,Ba-Ssalamah ^[2] ; Sarah,Poetter-Lang ^[1] ; Raphael,Ambros ^[1] ; Antonia,Kristic ^[1] ; David,Lauber ^[1] ; Katharina,Pomej ^[3] ; Teresa,Binter ^[3] ; Benedikt,Simbrunner ^[3] ; Georg,Semmler ^[3] ; Lorenz,Balcar ^[3] ; Yesim,Bican ^[1] ; Jacqueline C,Hodge ^[1] ; Thomas,Wrba ^[4] ; Michael,Trauner ^[5] ; Thomas,Reiberger ^[3] ; Mattias,Mandorfer ^[3]

作者单位： Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria. ^[1] Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria. Electronic address: ahmed.ba-ssalamah@meduniwien.ac.at. ^[2] Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria; Vienna Hepatic Hemodynamic Lab, Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria. ^[3] IT4Science, Medical University of Vienna, Vienna, Austria. ^[4] Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria. ^[5]

关键词 Cirrhosis Magnetic resonance imaging Portal hypertension gadolinium methoxybenzyl DTPA hepatobiliary contrast agent